Click here for Teams Link:

Objectives

  • Contextualize the current standard of care therapies for patients with Wilms Tumor with the history of discovery and first treatments and recognize the evolution of risk stratification as the backbone of clinical trial development in Wilms Tumor.
  • Appraise the presented supporting data on prognostic features of outcomes for patients with Wilms Tumor and evaluate the incorporation of this information into the upcoming Children’s Oncology Group therapeutic protocol for the Risk Stratified Treatment of patients with Stage I- I.

Practice Change

  • Apply the epidemiology and clinical presentation of Wilms Tumor to appropriate surveillance and/or diagnostic evaluation for children at known risk due to underlying genetic syndromes or with presentation of signs and symptoms consistent this diagnosis.

 

PDF icon “To view additional information on the Nemours Children’s disclosure policy, right click on this link to open in a new window.”

This Microsoft Teams service includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. By joining this session, you automatically consent to such recordings. If you do not consent to the recording, discuss your concerns with the meeting host prior to the start of the recording or do not join the session. Please note that any such recordings may be subject to discovery in the event of litigation.

Session date: 
09/18/2024 - 8:00am to 9:00am EDT
Location: 
  • 1.00 MOC ABS – Surgery
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
  • 1.00 AMA PRA Category 1 Credit

    The Nemours Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The Nemours Foundation designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Continuing Education
    This activity is designated for 1.00 continuing education credits.
  • 1.00 Nursing Contact Hour – Florida Board of Nursing

    Provider approved by the Florida Board of Registered Nursing. Provider number # 50-1428.

    This activity is designated for 1.00 contact hours.

Please login or register to take this course.